STIPE Therapeutics ApS
CVR 39691175 · Private limited company (ApS) · In bankruptcy
STIPE Therapeutics ApS is a Private limited company (ApS), founded on , based in København V. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. STIPE Therapeutics ApS went bankrupt on – 7.6 years after it was founded. 6 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2023) shows equity of DKK -2.5m and a net result of DKK -4.5m.
Bankruptcy
- Bankruptcy date
- Status
- In bankruptcy proceedings
- First distress status
- In voluntary liquidation from
- Age at bankruptcy
- 7.6 years
Company details
- CVR number
- 39691175
- Status
- In bankruptcy
- Company type
- Private limited company (ApS)
- Founded
- Address
- c/o Gorrissen Federspiel, Axeltorv 2
1609 København V - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 259k
- Employees
- 5 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 5 |
| Missing annual report | No |
| Negative equity | Yes |
| Equity ratio | -77.6% |
| Current ratio | 570% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 184 |
| Going-concern uncertainty | Yes |
Financials and key figures
| Financial year | 2023 | 2022 |
|---|---|---|
| Gross profit | DKK -3.5m | DKK -6.6m |
| Net profit | DKK -4.5m | DKK -8.3m |
| Equity | DKK -2.5m | DKK 2.0m |
| Total assets | DKK 3.2m | DKK 6.2m |
| Cash | DKK 2.3m | – |
| Short-term debt | DKK 565k | – |
| Avg. employees | 14 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2024 – 31 Dec 2024 | 184 | Late | |
| 1 Jan 2023 – 31 Dec 2023 | 129 | ||
| 1 Jan 2022 – 31 Dec 2022 | 151 | ||
| 1 Jan 2021 – 31 Dec 2021 | 124 | ||
| 1 Jan 2020 – 31 Dec 2020 | 125 | ||
| 2 Jul 2018 – 31 Dec 2019 | 121 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Claus Elsborg Olesen | ||
| CEO | Martin Roelsgaard Jakobsen | ||
| Board | Sten Verland | ||
| Board | Morten Døssing | ||
| Board | Martin Roelsgaard Jakobsen | ||
| Board | Christian Schetter | ||
| Board | Jonathan Leslie Tobin | ||
| Board | Regina Hodits | ||
| Board | Natalie Rose Sacks | ||
| Board | John Stephen Cassidy | ||
| Board | Mark David Chin | ||
| Owner (5%) | CLAUS OLESEN HOLDING ApS | Current | |
| Owner (10%) | MR Jakobsen Holding ApS | Current | |
| Owner (20%) | Wellington Partners V Life Sciences Fund | Current | |
| Owner (20%) | Sunstone Life Science Ventures Fund IV K/S | Current | |
| Owner (25%) | Novo Holdings A/S | Current | |
| Owner (33%) | CLAUS OLESEN HOLDING ApS | ||
| Owner (50%) | MR Jakobsen Holding ApS | ||
| Owner (15%) | Novo Holdings A/S | ||
| Owner (15%) | CLAUS OLESEN HOLDING ApS | ||
| Owner (10%) | Sunstone Life Science Ventures Fund IV K/S | ||
| Owner (20%) | MR Jakobsen Holding ApS | ||
| Owner (10%) | Wellington Partners V Life Sciences Fund | ||
| Owner (15%) | Arix Bioscience Holdings Limited | ||
| Owner (10%) | CLAUS OLESEN HOLDING ApS | ||
| Owner (15%) | MR Jakobsen Holding ApS | ||
| Owner (20%) | Novo Holdings A/S | ||
| Owner (15%) | Sunstone Life Science Ventures Fund IV K/S | ||
| Owner (15%) | Wellington Partners V Life Sciences Fund | ||
| Owner (20%) | Arix Bioscience Holdings Limited | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Founder | CLAUS OLESEN HOLDING ApS | Current | |
| Founder | MR Jakobsen Holding ApS | Current |
The CEOs' other companies
Claus Elsborg Olesen – 10 other companies
- CLAUS OLESEN HOLDING ApS Active
- Ceoth ApS Active
- Initiator Pharma A/S Active
- Kariya Pharmaceuticals ApS Active
- MACOL SAILING ApS Opløst
- MATCH RACE CENTER ÅRHUS ApS Opløst
- NMD Pharma A/S Active
- PCOVERY ApS Opløst
- Sulis Therapeutics ApS Active
- Synuca Therapeutics ApS Active
Martin Roelsgaard Jakobsen – 3 other companies
- MR Jakobsen Holding ApS Active
- Sulis Therapeutics ApS Active
- UNIKUM Therapeutics ApS Active
Address history (4 moves)
| c/o Gorrissen Federspiel, Axeltorv 2, 1609 København V | |
| Inge Lehmanns Gade 10, 8000 Aarhus C | |
| c/o The Kitchen, Peter Sabroes Gade 7, 8000 Aarhus C | |
| c/o AU The Kitchen, Nørrebrogade 44, 8000 Aarhus C | |
| c/o Olesen, Lyngsiesvej 18, 8230 Åbyhøj |
Employees per year
Other companies at the same address
- Autca ApS Bankrupt
- Autxad ApS Bankrupt
- CREATORS HOLDING IVS Bankrupt
- Convex Energy ApS Bankrupt
- Datoselskabet af 08.08.2024 ApS Bankrupt
- Datoselskabet af 31. maj 2007 ApS Bankrupt
- EnPro Denmark ApS Bankrupt
- Exchange Technology Holding ApS Bankrupt
- FANQUANTS ApS Bankrupt
- KP CONSULTING ApS Bankrupt
- Orchid ApS Bankrupt
- PROCURATIO GRUPPEN A/S Bankrupt
- Purpose Gum ApS Bankrupt
- Red Raccoon IVS Bankrupt
- Selskabet af 24. januar 2019 ApS Bankrupt
- Supsur ApS Bankrupt
- Swapsafe A/S Bankrupt
- Swapsafe Production ApS Bankrupt
- TKS Group ApS Bankrupt
- 3PART A/S Active
- 3PART SUCCEED ApS Active
- 89x Startup Studio ApS Active
- 91x ApS Active
- AI Select ApS Active
- ANDERS KASTBERG ApS Active
Similar companies in København
- Resiliency Centre ApS Aarhus N
- SymbioMatch ApS Aarhus C
- AptaShape ApS Aarhus C
- Aptamist ApS Lystrup
- Mmimetika ApS Aarhus N
- MKR Finans APS Aarhus C
- Cystotech ApS Aarhus C
- IMCOR ApS Egå
- Commit Biologics ApS Aarhus C
- Økologisk Komplementarselskab ApS Aarhus N
- MyGold ApS Aarhus C
- UNIKUM Therapeutics ApS Risskov
Questions and answers about STIPE Therapeutics ApS
Has STIPE Therapeutics ApS gone bankrupt?
Yes. STIPE Therapeutics ApS went bankrupt on 3 February 2026.
Who is the auditor of STIPE Therapeutics ApS?
STIPE Therapeutics ApS most recently used EY Godkendt Revisionspartnerselskab.
When was STIPE Therapeutics ApS founded?
STIPE Therapeutics ApS was founded on 2 July 2018.
What is the equity of STIPE Therapeutics ApS?
Equity was DKK -2.5m according to the annual report for the period ending 31 December 2023.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.